Investors & Media
Company Overview
UNITY Biotechnology is developing therapeutics to slow, halt or reverse diseases of aging. UNITY's initial focus is on creating medicines that target cellular senescence and aging-related biology in ophthalmologic and neurologic diseases, while leveraging partnerships in growth areas with high unmet need.
Stock Information
Data Provided by Refinitiv. Minimum 15 minutes delayed.
